ArticleJournal of acquired immune deficiency syndromes (1999)2012

The activity of the integrase inhibitor dolutegravir against HIV-1 variants isolated from raltegravir-treated adults.

Mark R Underwood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.